These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1898789)
21. Comparison of calculated and observed residual risks of transfusion-transmitted hepatitis C virus infection in multiply transfused patients. French Study Group on Thalassaemia. de Montalembert M; Lefrère JJ; Micheau M; Girot R Transfusion; 1994 Aug; 34(8):737-8. PubMed ID: 8073492 [No Abstract] [Full Text] [Related]
22. Posttransfusion hepatitis C virus infection in children. Ni YH; Chang MH; Lue HC; Hsu HY; Wang MJ; Chen PJ; Chen DS J Pediatr; 1994 May; 124(5 Pt 1):709-13. PubMed ID: 8176556 [TBL] [Abstract][Full Text] [Related]
23. "Look back" program initiated for hepatitis C infection. Randal J J Natl Cancer Inst; 1999 Jun; 91(11):907. PubMed ID: 10359540 [No Abstract] [Full Text] [Related]
25. Hepatitis C infection after blood product transfusion. Kelly DA Arch Dis Child; 1996 Nov; 75(5):363-5. PubMed ID: 8957946 [TBL] [Abstract][Full Text] [Related]
26. High frequency of antibodies to syphilis and HIV in hepatitis C virus positive blood donors may reflect its sexual transmission in this region. Mittal A Sex Transm Infect; 2003 Apr; 79(2):170-1. PubMed ID: 12690148 [No Abstract] [Full Text] [Related]
31. Hepatitis C virus RNA in symptomless donors implicated in post-transfusion non-A, non-B hepatitis. Zanetti AR; Tanzi E; Zehender G; Magni E; Incarbone C; Zonaro A; Primi D; Cariani E Lancet; 1990 Aug; 336(8712):448. PubMed ID: 1974982 [No Abstract] [Full Text] [Related]
32. Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepatitis. Yoshizawa H; Nojiri N; Takahashi K Lancet; 1991 Jan; 337(8732):47-8. PubMed ID: 1670664 [No Abstract] [Full Text] [Related]
33. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors. Smith BC; Chapman CE; Burt AD; Toms GL; Bassendine MF QJM; 1997 Sep; 90(9):587-92. PubMed ID: 9349451 [TBL] [Abstract][Full Text] [Related]
34. Hunt begins for patients suspected of having hepatitis C. Court C BMJ; 1995 Jan; 310(6973):146-7. PubMed ID: 7833744 [No Abstract] [Full Text] [Related]
35. Countries struggle with hepatitis C contamination. Zinn C; Dyer O; Dorozynski A; Karcher H; Roberts J BMJ; 1995 Feb; 310(6977):417-8. PubMed ID: 7873942 [No Abstract] [Full Text] [Related]
36. Ireland deals with hepatitis C fallout. Murdoch A BMJ; 1995 Apr; 310(6985):958. PubMed ID: 7728024 [No Abstract] [Full Text] [Related]
37. Concerns about "lookback" exercise for hepatitis C. Higson N BMJ; 1995 Oct; 311(7010):953. PubMed ID: 7580586 [No Abstract] [Full Text] [Related]
38. [Procedure of Look Back (pursuant to 19 Transfusion Law). At the 62nd meeting of the Work Group Blood on June 14, 2006 the following vote (V 34) was passed]. Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):940-57. PubMed ID: 16953363 [No Abstract] [Full Text] [Related]
39. Incidence of transfusion associated B and non-A, non-B hepatitis in Italy. Mele A; Stroffolini T; Catapano R; Palumbo F; Moiraghi A; Novaco F BMJ; 1995 Sep; 311(7009):846-7. PubMed ID: 7580492 [No Abstract] [Full Text] [Related]
40. Pressure mounts over patients with hepatitis C. Dyer C BMJ; 1994 Nov; 309(6966):1389. PubMed ID: 7819838 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]